Cabometyx Norway

Cabometyx in Europe

This is a promotional website intended for Healthcare Professionals in Norway

Resources

Handbook CABOMETYX . Side effect management of CABOMETYX and TKI

Nurse broschure(Når pasientener foreskrevet Cabometyx)

Detail Aid. Information about METEOR and CABOSUN trial and how to use CABOMETYX

Reprint – Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial «T Choueiri et al – The Lancet Oncology

Reprint – Cabozantinib versus  sunitinib as initial therapy(CABOSUN) T Choueiri et al – The European Journal of Cancer

Resources

© Ipsen Group 2020 Last updated on: October 2019. This site is published by Ipsen, which is solely responsible for the content. It is intended only for healthcare professionals from the Norway Healthcare professionals from outside the EU, as well as any non-healthcare professionals, are excluded from the intended audience. CBZ-ALL-001685

Welcome to Cabometyx.no website. This website is intended for Norway Healthcare professionals only.

Please confirm below that you are a registered healthcare professional.

I AM A NORWEGIAN HEALTHCARE PROFESSIONAL

I AM A EU HEALTHCARE PROFESSIONAL

I AM NOT A HEALTHCARE PROFESSIONAL